After Sustained HCV Virologic Response to DAAs, MASLD Increases HCC Risk
MASLD affects the development of hepatocellular carcinoma following SVR in chronic hepatitis C.
Related Articles
Beyond the Noise #77: A ‘modest’ number of deaths – Beyond the Noise
One new member of the CDC vaccine advisory dismissed pediatric deaths from influenza, calling 250 a ‘modest’ number of deaths.
The Grand Roundup
We are introducing a new way to deliver the most relevant information you need for your patients on the topics that matter most to your…
Saudi Arabia Reports Eleven MERS Cases, Two Fatalities
The World Health Organisation Eastern Mediterranean Region (WHO EMRO) recently reported one new case of Middle East respiratory syndrome coronavirus (MERS) in Saudi Arabia. Since the…
Bangladesh dengue deaths top 100, August could be worse
Health experts are warning that August could bring an even more severe outbreak of the mosquito-borne disease.
CDC union says vaccine misinformation put staff at risk after Atlanta shooting
Deadly violence not random as staff have endured ‘months of mistreatment, neglect and vilification’, says union
CDC shooter blamed COVID vaccine for depression; union demands statement against misinformation
A Georgia man who had blamed the COVID-19 vaccine for making him depressed and suicidal has been identified as the shooter who opened fire late…
C.D.C. Workers Say Shooting Manifests Worst Fears About Anger Among Public
Employees expressed horror at a shooting at the agency’s headquarters, and some said they viewed it as part of a pattern of threats and assaults…
CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech
Germany’s CureVac and Britain’s GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the mRNA vaccine technology that was at…